Body mass index and serum markers associated with progression-free survival in lung cancer patients treated with immune checkpoint inhibitors. Liu Z, Diao Y, Li X. BMC Cancer 2022;22:824.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu Z, Diao Y, Li X. Body mass index and serum markers associated with progression-free survival in lung cancer patients treated with immune checkpoint inhibitors. BMC Cancer 2022;22:824.
PMID: 35902908